U.S. drugmakers Johnson & Johnson and Eli Lilly increased spending on security for their top executives in 2024, with both citing increased threats after a UnitedHealth insurance executive was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback